Welcome to Keloid Research Foundation

Established in 2011 by Dr. Michael H. Tirgan, the KRF is a non for profit medical research and educational organization. The mission of KRF is to foster scientific research in keloid disorder and to promote education, advocacy, and service to those who suffer from this disorder.

Keloid is a genetic skin disorder which results in excessive growth and formation of tumor like areas in an otherwise healthy skin. Despite their benign nature, keloids may constitute severe aesthetic as well as functional problems that can negatively impact patients' quality of life.

Keloids are mostly observed between ages of 10 and 30. There is no consensus on best method of treatment for this condition; neither do we have any form of wholly satisfactory therapy. Keloids do not regress and are characterized by a high rate of recurrence after surgery or other forms of treatment. Indeed, surgical treatment often gives rise to even larger lesions. In addition, being a uniquely human condition, no animal study models are available.

Although a common medical condition, keloid disorder has been neglected by the research community. There are no statistics as to its incidence and prevalence, neither in United States, nor elsewhere in the world. This disorder, although quite common and although at times very disabling, has not captured interest of the research community and remains an area of unmet medical need. It behaves quite similar to cancer, yet it does not metastasize to tissues outside skin (or may be it does and we simply do not know about it).

KRF was formed to foster scientific research in this disease. To accomplish its goals, KRF will raise funds, increase awareness and bolster interest in this disease. We will not make any progress in this disease unless we dedicate same kind of interest, effort and energy that we have dedicated to cancer research.

KRF is a non for profit organization and needs your help to succeed. If you suffer from keloid, or are simply interested in helping this cause, please join us as a volunteer. We can use your help and support. Please take a moment to review our webpage about volunteer opportunities. If your skill set is not listed there and you believe you can help KRF, please contact us via e mail.

  • November 5, 2015
  • New York Keloid Symposium:
  • KRF is pleased to announce that it is in planning stages for its first Keloid Symposium to be held in September 2016 in New York City. Further details will be announced withing the upcoming months.
  • November 1, 2015
  • KRF presentations at ETRS 2015 meeting:
  • Dr. Michael H. Tirgan was invited and gave two talks on Keloid Disorder at the Keloid Satellite Symposium during the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society that was held 21-23 October 2015 in Copenhagen, Denmark.

  • August 15, 2015
  • Atlas of Ear Keloids:
  • KRF is pleased to announce publication of it first sponsored book, Atlas of Ear Keloids. This full color atlas, authored by Dr. Michael Tirgan, provides an insight into natural history of ear keloids. With over 130 full color images of ear keloids, Dr. Tirgan provides a solid proof that surgery is not a treatment for keloid disorder.

    Atlas of Ear Keloids by Dr. Michael H. Tirgan

  • August 1, 2015
  • KRF presenting at ETRS 2015 meeting:
  • KRF was able to arrange for a scientific session dedicated to keloid research the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society that will be held 21-23 October 2015 in Copenhagen, Denmark. This will be the very first dedicated scientific session that KRF has been able to organize.

  • November 11, 2011
  • KRF Formally Registered in New York State
  • KRF is pleased to announce that its Certificate of Incorporation was accepted and filled by the State of New York. KRF is now able to conduct fund raising activities to support conduct of much needed research in the field of Keloid.
  • October 18, 2011
  • Grant Approval from Rockefeller University
  • KRF is pleased to announce that Dr. Tirgan's proposal to study "Pathogenesis of Keloid" was approved by the Rockefeller University Center for Clinical and Translational Sciences. (RUCCTS Grant # 2UL1RR024143 from the National Center for Research Resources, National Institutes of Health). We thank Rockefeller University for extending support to our fight against keloid disorder. www.KeloidTissueBank.com is the official website of the main study.
  • October 14, 2011
  • Dr. James N. Musyoka, joins KRF
  • KRF is pleased to announce that Dr. Musyoka has joined KRF. Dr. Musyoka has just completed his PhD with focus on would healing and keloid research and has previously conducted laboratory research in this area. We welcome Dr. Musyoka as a new member of KRF.
  • August 4, 2011
  • Dr. Djoned Sananto joins KRF
  • KRF is pleased to announce that Dr. Sananto, Head of Plastic Surgery Department at Haji General Hospital in Indonesia, has joined KRF. Dr. Sananto has strong interest in keloid disorder, actively treats patients with keloids, has previously conducted laboratory research in keloid and published the study results. We welcome Dr. Sananto as a new member of KRF.
  • July 28, 2011
  • Advanced Pathology Laboratory Partners with KRF
  • KRF is pleased to announce that the Director of Advanced Pathology Laboratory, Dr. Ali Daneshvar, has made a long term commitment to serve as the Tissue Bank arm of KRF. Advanced Pathology Laboratory is a CLIA certified full service pathology laboratory, located in Northfiled, New Jersey.
  • July 21, 2011
  • KRF Appoints General Counsel
  • KRF is pleased to announce appointment of its General Counsel. Attorney Ronald R. Benjamin of Binghamton, New York has been appointed General Counsel for Keloid Research Foundation. He will oversee all legal matters that concern operations of KRF. Mr. Benjamin has been practicing public interest law since 1979.
  • July 18, 2011
  • Certificate of Incorporation for KRF
  • The Certificate of Incorporation for KRF was completed by three initial board members, Michael Tirgan, MD acting as the Medical Officer, Nadereh Nouhi acting as the Business Manager and Alexander Duggan acting as the Patient Advocate and Liaison.